Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders (vol 55, pg 330, 2018)

被引：0
|
作者：
Kocaman, Gulsen [1 ]
Kahraman, Nese [2 ]
Gurkan Koseoglu, Banu [2 ]
Bilgic, Basar [3 ]
Matur, Zeliha [4 ]
Ertas, Mustafa [5 ]
Gulsen, Yesim [3 ]
Baykan, Betul [3 ]
机构：
[1] Bezmialem Vakif Univ, Dept Neurol, Fac Med, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Dent, Dept Maxillofacial Surg, Istanbul, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey
[4] Istanbul Bilim Univ, Dept Neurol, Fac Med, Istanbul, Turkey
[5] Private Off, Neurol, Istanbul, Turkey
来源：
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | 2019年 / 56卷 / 01期
关键词：
D O I：
10.29399/npa.23634
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [1] Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders
    Kocaman, Gulsen
    Kahraman, Nese
    Gurkan Koseoglu, Banu
    Bilgic, Basar
    Matur, Zeliha
    Ertas, Mustafa
    Gulsen, Yesim
    Baykan Baykal, Betul
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2018, 55 (04): : 330 - 336
  • [2] OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine (vol 78, pg 589, 2018)
    Frampton, James E.
    Silberstein, Stephen
    DRUGS, 2018, 78 (06) : 715 - 715
  • [3] Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine (vol 55, pg 1218, 2015)
    Maasumi, K.
    Thompson, N. R.
    Kriegler, J. S.
    Tepper, S. J.
    HEADACHE, 2016, 56 (02): : 449 - 449
  • [4] OnabotulinumtoxinA for the prophylactic treatment of headaches in adult patients with chronic migraine: a safety evaluation
    Cheng, Fan
    Ahmed, Fayyaz
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (11) : 1275 - 1289
  • [5] OnabotulinumtoxinA Treatment Satisfaction among Patients with Chronic Migraine
    Tockhorn-Heidenreich, A.
    Ford, J.
    Jackson, J.
    Ye, W. Wenyu
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 891 - 891
  • [6] Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study
    Alpuente, A.
    Gallardo, V. J.
    Torres-Ferrus, M.
    Santos-Lasaosa, S.
    Guerrero, A. L.
    Lainez, J. M.
    Viguera, J.
    Gago-Veiga, A.
    Irimia, P.
    del Rio, M. Sanchez
    Pozo-Rosich, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (10) : 2102 - 2108
  • [7] OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience
    Chiang, Chia-Chun
    Starling, Amaal J.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (12) : 397 - 406
  • [8] OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia
    Sastre Real, Maria
    Diaz de Teran, Javier
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [9] OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use (vol 34, pg 1287, 2020)
    Frampton, James E.
    CNS DRUGS, 2021, 35 (06) : 701 - 701
  • [10] OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use (vol 34, pg 1287, 2020)
    Frampton, James E.
    CNS DRUGS, 2021, 35 (01) : 135 - 135
12345